Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Neuromuscular Junction Disorders I

Thursday 04/21/16
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­
Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic
Event Timeline
01:00 PM - 01:05 PM Introduction
01:05 PM - 01:55 PM Presentation and Diagnosis of Myasthenia Gravis
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­
01:55 PM - 02:45 PM Treating Myasthenia Gravis in 2016
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­
02:45 PM - 03:00 PM Discussion
Faculty Disclosures
Laura M. Tormoehlen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.
Jeff Guptill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Janice M. Massey, MD, FÂ鶹´«Ã½Ó³»­ Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .